Amdocs Limited (NASDAQ:DOX) Shares Sold by Truist Financial Corp

Truist Financial Corp lowered its stake in Amdocs Limited (NASDAQ:DOXFree Report) by 2.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,773 shares of the technology company’s stock after selling 1,520 shares during the period. Truist Financial Corp owned about 0.06% of Amdocs worth $5,781,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of DOX. GAMMA Investing LLC acquired a new stake in Amdocs in the 4th quarter valued at about $25,000. Operose Advisors LLC raised its position in Amdocs by 148.0% in the 3rd quarter. Operose Advisors LLC now owns 310 shares of the technology company’s stock valued at $26,000 after purchasing an additional 185 shares in the last quarter. Oakworth Capital Inc. acquired a new stake in Amdocs in the 4th quarter valued at about $26,000. VisionPoint Advisory Group LLC increased its holdings in shares of Amdocs by 77.7% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 503 shares of the technology company’s stock valued at $42,000 after acquiring an additional 220 shares during the last quarter. Finally, Allworth Financial LP increased its holdings in shares of Amdocs by 16,840.0% in the 3rd quarter. Allworth Financial LP now owns 847 shares of the technology company’s stock valued at $72,000 after acquiring an additional 842 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Trading Up 0.3 %

NASDAQ:DOX opened at $83.90 on Friday. The stock’s 50 day moving average price is $88.95 and its 200 day moving average price is $87.43. The company has a market capitalization of $9.86 billion, a PE ratio of 17.97, a P/E/G ratio of 1.36 and a beta of 0.70. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 52-week low of $78.38 and a 52-week high of $99.75.

Amdocs (NASDAQ:DOXGet Free Report) last released its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.16. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter last year, the business posted $1.33 EPS. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. On average, research analysts anticipate that Amdocs Limited will post 5.87 EPS for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Shareholders of record on Friday, March 29th were given a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a yield of 2.28%. This is a boost from Amdocs’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Wednesday, March 27th. Amdocs’s dividend payout ratio (DPR) is presently 41.11%.

Analyst Upgrades and Downgrades

DOX has been the topic of a number of recent analyst reports. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, March 15th. Citigroup increased their price objective on Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, Barclays increased their price objective on Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, February 8th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $108.60.

Get Our Latest Stock Analysis on Amdocs

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Recommended Stories

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.